Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Filings indexed 1,098 across all filing types
Latest filing 2020-06-29 AGM Information
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Updates
AGM Information Classification · 95% confidence The document is a formal notice addressed to stock exchanges about the convening of the 26th Annual General Meeting (AGM) of the company. It mentions the date of the AGM, the mode of the meeting (video conference), and the cut-off date for voting. There is no financial data, detailed report, or results included. The document is an announcement related to the AGM, specifically the intimation of the meeting date and arrangements. Given the content and length (1509 characters), this fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or about the AGM, including notices of the meeting.
2020-06-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges about the schedule of analyst and institutional investor meetings, specifically a conference call scheduled for June 29, 2020. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, indicating it is a regulatory disclosure. The content is an announcement of a meeting schedule rather than a financial report, earnings release, or detailed investor presentation. The document length is short (1966 characters), and it does not contain financial data or detailed analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2020-06-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated June 26, 2020, addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is an intimation or announcement about upcoming investor meetings, not a financial report or detailed presentation. The document length is only 1804 characters, indicating it is a brief announcement rather than a full report. There is no financial data, no detailed analysis, no voting results, no management changes, or other report content. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about investor meetings and does not fit other specific categories.
2020-06-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated June 19, 2020, addressed to stock exchanges (NSE and BSE) regarding the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is an intimation about planned conference calls with investors on June 22, 2020. There is no financial data, no detailed report, no voting results, no management changes, or other substantive filings. The document is essentially an announcement of scheduled investor meetings, which fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit any other specific category. The document length is short (1765 characters), and it is not a report or transcript itself, but an intimation of meetings.
2020-06-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated June 15, 2020, addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is about informing the stock exchanges of upcoming investor meetings, specifically a one-on-one conference call scheduled for June 17, 2020. There is no financial data, no detailed report, no earnings or management discussion, and no voting or capital structure information. The document is an announcement of a meeting schedule, which fits best under Regulatory Filings (RNS) as a general regulatory announcement and disclosure. The document length is short (1636 characters), and it is not a report or transcript but a notification of an event.
2020-06-15 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges referencing compliance under Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It encloses Related Party Transactions for the half year ended March 31, 2020. The document is short (1371 characters) and appears to be an announcement or submission of related party transaction information rather than a full financial report. It does not contain financial statements or detailed analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous compliance and regulatory announcements that do not fit other categories.
2020-06-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.